TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Nov 7, 7:02 AM ET

Zaks Tal Zvi 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Nov 7, 2022

Insider Transaction Report

Form 4
Period: 2022-11-04
Zaks Tal Zvi
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-11-04+12,20512,222 total
  • Exercise/Conversion

    Restricted Share Units

    2022-11-0412,2050 total
    Ordinary Shares (12,205 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on November 4, 2021 and vested on November 4, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION